CoreWeave (CRWV) insider sale notice shows $2.0M proposed sale, prior $24.8M 10b5-1 trade

Rhea-AI Filing Summary

CoreWeave, Inc. (CRWV) filed a Form 144 notifying a proposed sale of 19,410 common shares through Morgan Stanley Smith Barney at an aggregate market value of $2,000,006.40, with an approximate sale date of 09/02/2025. The filing lists 370,470,348 shares outstanding, and shows these shares were acquired as Founders Shares on 12/27/2023. The filing also discloses prior 10b5-1 sales on 08/20/2025 including 281,250 shares for West Clay Capital LLC (gross proceeds $24,777,421.88) and two sales of 21,531 shares each for two trusts (gross proceeds $1,896,827.27 each). The notice includes the standard signature representation that the seller is not aware of undisclosed material adverse information.

Positive

• Transparent disclosure of proposed insider sale including broker, share count, acquisition details, and representation about material information
• Proposed sale size is small relative to total shares outstanding (19,410 vs 370,470,348), limiting immediate dilution or ownership change

Negative

• Significant prior 10b5-1 sale of 281,250 shares on 08/20/2025 with gross proceeds of $24,777,421.88 may indicate insider liquidity-taking
• Filing provides no operational or financial context about the issuer, so investor interpretation of the sales relies solely on transaction disclosure

Insights

Securities Analyst

TL;DR: Insider-linked sales disclosed; proposed sale is small relative to total shares but recent 10b5-1 transactions show significant realized proceeds.

The filing reports a proposed sale of 19,410 common shares valued at $2.0 million and confirms acquisition as founders shares dated 12/27/2023. Relative to 370.5 million shares outstanding, the proposed sale represents a negligible ownership reduction. However, the prior 10b5-1 sale of 281,250 shares generating roughly $24.8 million is sizable and represents actual liquidity taken by related parties. For investors, the filings document transparency of planned insider-related sales but do not provide operational or financial performance details.

Corporate Governance Expert

TL;DR: Form 144 is routine compliance for planned insider sales; disclosures align with Rule 144 and 10b5-1 reporting.

The notice includes required specifics: broker name, share counts, acquisition date and nature (founders shares), and representation about absence of undisclosed material information. The presence of multiple 10b5-1 sales on 08/20/2025 indicates prearranged trading plans or instructions were used to execute earlier sales. The filing does not state any departures, governance changes, or material adverse events; its governance implication is primarily transparency around insider liquidity.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	19410	2000006.40	370470348	09/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/27/2023	Founders Shares	Issuer			19410	12/27/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for WEST CLAY CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/20/2025	281250	24777421.88
10b5-1 Sales for YOLO APV TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/20/2025	21531	1896827.27
10b5-1 Sales for YOLO ECV TRUST 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	08/20/2025	21531	1896827.27

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed by CRWV disclose?

The Form 144 discloses a proposed sale of 19,410 common shares valued at $2,000,006.40 through Morgan Stanley with an approximate sale date of 09/02/2025.

How many shares does CoreWeave have outstanding according to the filing?

The filing reports 370,470,348 shares outstanding.

When were the shares proposed for sale originally acquired?

The shares were acquired as Founders Shares on 12/27/2023.

Were there recent related sales disclosed in the filing?

Yes. The filing shows 10b5-1 sales on 08/20/2025 including 281,250 shares for West Clay Capital LLC (gross proceeds $24,777,421.88) and two sales of 21,531 shares each for two trusts (gross proceeds $1,896,827.27 each).

Does the Form 144 state the seller knows of any undisclosed material adverse information?

By signing the notice the seller represents they do not know any material adverse information